查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404810

植入式心臟整流去颤器市场规模、份额、趋势分析报告：按 NYHA 类别、最终用途、产品类型、地区和细分市场预测，2024-2030 年

Implantable Cardioverter Defibrillators Market Size, Share & Trends Analysis Report By NYHA Class (NYHA Class I, NYHA Class II), By End-use (Hospitals, Ambulatory Surgical Centers), By Product Type, By Type, By Region, & Segment Forecasts, 2024-2030
出版日期: | 出版商: Grand View Research | 英文 174 Pages | 商品交期: 2-10个工作天内

价格

植入式心臟整流去颤器市场成长与趋势：

Grand View Research 的最新报告显示，到 2030 年，全球植入式心臟整流去颤器市场预计将达到 58.6 亿美元。

预计2024年至2030年该市场将以6.4%的复合年增长率成长。这一增长可归因于多种因素，包括产品技术的进步、心臟麻痹发生率的增加、公众对心臟健康意识的提高以及政府和医疗机构的支持政策。这些因素共同推动了心臟去颤器的需求，并有助于整体市场的扩张。

心血管和其他心臟疾病的盛行率不断上升，推动了全球对心臟再同步治疗设备 (CRT-D) 和植入式心臟整流去颤器(ICD) 的需求。心臟麻痹(SCA) 仍然是重要的死亡原因，其发生率和相关危险因子不断增加。心臟衰竭对全球健康挑战造成重大影响，增加了对 CRT-D 和心臟去颤器的需求。此外，心律异常的普遍存在，尤其是老年人和冠状动脉疾病 (CAD) 患者，进一步推动了对 ICD 的需求。 CRT-D 和 ICD 在心血管疾病的治疗和改善患者预后方面变得越来越重要。

ICD 市场受到了 COVID-19大流行的负面影响。选择性手术的取消和对 COVID-19 患者的关注对 2020 年第一季的市场产生了影响。然而，大流行加速了远端保健的采用，包括对心律不整患者的远距监测。心律协会发布的指南强调限制面对面咨询并提倡远距医疗咨询。 Biotronic 充分利用了这一趋势，普及了配备家庭监控技术的植入式 CRM 设备。儘管心血管远端监测有所增长，但在某些地区（包括一些欧盟国家）报销仍然有限，阻碍了整体市场的扩张。调查对象国家尚未获得用于心臟衰竭管理的远端技术的报销。

植入式心臟整流去颤器市场报告亮点

  • 根据产品类型，ICD 市场分为经静脉植入式心臟整流去颤器(T-ICD) 和皮下植入式心臟整流去颤器(S-ICD)。 2023年，T-ICD细分市场将以89.83%的市场占有率主导地位。
  • 依类型，ICD 市场分为单心室 ICD、双心室 ICD 和双心室 ICD。 2023年，双心室设备细分市场占据主导地位，销售份额为44.33%。
  • 依NYHA等级，市场分为NYHA II级和NYHA III级。 NYHA II 类细分市场预计将在 2023 年以 67.72% 的份额主导市场，并在市场估计和预测期内以 6.6% 的复合年增长率增长最快。
  • 根据最终用途，ICD 市场分为医院、门诊手术中心等。预计到2023年，医院细分市场将以86.67%的份额占据市场主导地位，并在市场估计和预测期内以6.5%的最快复合年增长率增长。
  • 按地区划分，北美主导全球市场，2023年占总市场占有率的41.4%。北美拥有高度发展的医疗保健基础设施，包括医院、诊所和医疗设施。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章植入式心臟整流去颤器市场变数与趋势

  • 植入式心臟整流去颤器（ICD）市场前景
    • 母市场展望 -心率管理设备市场
    • 附随市场前景
  • 市场动态
    • 市场驱动因素影响分析
    • 市场抑制因素分析
  • 法律规范
    • 标准和合规性
    • 赎回场景
  • COVID-19感染疾病的影响
  • 心臟衰竭ICD 患者人数
  • 接受电池更换的 ICD 患者比例及併发症率
    • 接受电池更换的 ICD 患者百分比
    • 併发症率
  • ICD治疗相关临床实验评价
    • 心肌病多部位刺激（Mustik）试验
    • 多中心 Insync 随机临床评估（奇蹟）试验
    • Hf（伴同性）试验中药物治疗、起搏和去心房颤动的比较
    • 心臟再同步-HF (Care-HF) 试验
    • 多中心自动心臟去颤器植入合併心臟再同步治疗（Madit-crt）试验
    • 丹麦研究评估植入式心臟整流去颤器对非缺血性心臟衰竭衰竭死亡率患者的疗效（丹麦）试验
    • 英国审判
  • 产业分析工具
    • 波特的分析
    • 宏观经济分析

第四章植入式心臟整流去颤器市场：产品类型分析

  • 2023 年和 2030 年产品类型变化分析和市场占有率
  • 依产品类型
  • 植入式心臟整流去颤器(T-ICD)
    • 2018-2030年植入式心臟整流去颤器市场
  • 植入式心臟整流去颤器(S-ICD)
    • 皮下植入式心臟整流去颤器市场，2018-2030

第五章植入式心臟整流去颤器市场：类型分析

  • 2023年和2030年类型变化分析和市场占有率
  • 按类型
  • 单腔ICD
    • 使用单腔 ICD 的患者的常见症状
    • 单腔 ICD 市场，2018-2030 年
  • 双腔室ICD
    • 使用双腔 ICD 的患者的常见症状
    • 双腔室ICD 市场，2018-2030
  • 双心室装置
    • 双心室装置市场，2018-2030

第六章植入式心臟整流去颤器市场：NYHA 类别分析

  • 2023年和2030年尼哈级波动分析和市场占有率
  • 按膝盖等级
  • 尼哈II级
    • 尼哈 II 类市场，2018-2030
  • 尼哈Ⅲ级
    • Niha III 级市场，2018-2030

第七章植入式心臟整流去颤器市场：最终用途分析

  • 2023 年和 2030 年最终用途变化分析和市场占有率
  • 按最终用途
  • 医院
    • ICD植入的变化取决于医院类型
    • 医院市场，2018-2030
  • 门诊手术中心
    • 门诊手术中心市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第八章植入式心臟整流去颤器市场：区域估计和趋势分析

  • 植入式心臟整流去颤器市场：区域展望
  • 北美洲
    • 2018-2030年北美植入式心臟整流去颤器市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030 年欧洲植入式心臟整流去颤器市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018-2030 年亚太地区植入式心臟整流去颤器市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲植入式心臟整流去颤器市场估计与预测
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 2018-2030年中东和非洲植入式心臟整流去颤器市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章竞争分析

  • 公司分类
  • Participants'Overview
  • 财务绩效
  • 产品基准评效
  • 公司市场分析
    • 热图分析
  • Swot-analysis
    • Abbott
    • Medtronic
    • Biotronik Se &Co. Kg
    • Boston Scientific Corporation
    • Microport Scientific Corporation
    • Livanova Plc
  • 2023 年公司市场占有率分析
  • 策略规划
    • 併购
    • 产品发表会
    • 伙伴关係与协作
    • 产品核准
    • 其他的
Product Code: GVR-4-68040-109-4

Implantable Cardioverter Defibrillator Market Growth & Trends:

The global implantable cardioverter defibrillator market size is projected to reach USD 5.86 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 6.4% from 2024 to 2030. The growth can be attributed to various factors, including advancements in product technology, the increasing prevalence of sudden cardiac arrest, growing public awareness about cardiac health, and supportive policies by governments and healthcare organizations. These factors collectively drive the demand for cardioverter defibrillators and contribute to the overall market expansion.

The global demand for cardiac resynchronization therapy devices (CRT-Ds) and implantable cardioverter defibrillators (ICDs) is fueled by the increasing prevalence of cardiovascular diseases and other heart ailments. Sudden cardiac arrest (SCA) remains a significant cause of mortality, with a rising incidence and associated risk factors. Heart failure contributes significantly to global health challenges and drives the need for CRT-Ds and defibrillators. In addition, the prevalence of abnormal heart rhythms, especially in older adults and individuals with coronary artery disease (CAD), further boosts the demand for ICDs. These factors highlight the growing importance of CRT-Ds and ICDs in addressing cardiovascular conditions and improving patient outcomes.

The ICD market was negatively impacted by the COVID-19 pandemic. The suspension of elective surgeries and the focus on COVID-19 patients affected the market during the first quarter of 2020. However, the pandemic accelerated the adoption of telehealth, including remote monitoring for patients with arrhythmias. Guidelines released by the Heart Rhythm Society emphasized limiting in-person visits and promoting remote care. Biotronik capitalized on this trend by promoting its implantable CRM devices with home monitoring technology. Despite the growth in cardiovascular remote monitoring, limited reimbursement in specific regions including some EU countries hindered the overall market expansion. Approximately 13 surveyed countries still do not provide reimbursement for remote technologies in the context of heart failure management.

Implantable Cardioverter Defibrillator Market Report Highlights:

  • Based on product type, the ICD market is classified into transvenous implantable cardioverter-defibrillators (T-ICDs) and subcutaneous implantable cardioverter defibrillator segments (S-ICDs). The T-ICDs segment dominated the market in 2023 with a revenue share of 89.83%.
  • Based on type, the ICD market is classified into single-chamber ICDs, dual-chamber ICDs, and biventricular devices segments. The biventricular devices segment dominated the market in 2023 with a revenue share of 44.33%.
  • Based on NYHA Class, the market is classified into NYHA Class II and NYHA Class III. The NYHA Class II segment dominated the market with a 67.72% share in 2023 and is estimated to grow at the fastest CAGR of 6.6% during the forecast period.
  • Based on end-use, the ICD market is classified into hospitals, ambulatory surgical centers, and others. The hospitals segment dominated the market with a share of 86.67% in 2023 and is estimated to grow at the fastest CAGR of 6.5% during the forecast period.
  • In terms of region, the North America dominated the global market and accounted for 41.4% of the total market share in 2023. North America has a well-developed, advanced healthcare infrastructure, including hospitals, clinics, and medical facilities.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Product Type Segment
      • 1.1.1.2 Type Segment
      • 1.1.1.3 Nyha Class Segment
      • 1.1.1.4 End-use Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 GVR's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
      • 1.9.1.1 Research Scope And Assumptions
  • 1.10 List Of Secondary Sources
  • 1.11 List Of Primary Sources
  • 1.12 List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot-1
  • 2.3 Segment Snapshot - 2
  • 2.4 Competitive Landscape

Chapter 3. Implantable Cardioverter Defibrillators Market Variables And Trends

  • 3.1 Implantable Cardioverter Defibrillators (ICD) Market Lineage Outlook
    • 3.1.1 Parent Market Outlook - Cardiac Rhythm Management Devices Market
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Impact Analysis
      • 3.2.1.1 Increasing Prevalence Of Cardiovascular Diseases & Other Heart Ailments
      • 3.2.1.2 Growing Technological & Product Development Activities
      • 3.2.1.3 Recognition Of Subcutaneous ICDs
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Product Recalls
      • 3.2.2.2 Gender & Regional Implantation Disparity And Cybersecurity Concerns
  • 3.3 Regulatory Framework
    • 3.3.1 Standards And Compliances
      • 3.3.1.1 North America
      • 3.3.1.2 Europe
      • 3.3.1.3 Asia Pacific (Apac)
      • 3.3.1.4 Latin America (Latam)
      • 3.3.1.5 Middle East & Africa (Mea)
    • 3.3.2 Reimbursement Scenario
      • 3.3.2.1 U.S.
      • 3.3.2.2 Canada
      • 3.3.2.3 Germany
      • 3.3.2.4 UK
      • 3.3.2.5 Japan
      • 3.3.2.6 Australia
      • 3.3.2.7 China
  • 3.4 Impact Of Covid-19 Pandemic
  • 3.5 Volume Of ICD Patients Suffering Heart Failure
  • 3.6 Percentage Of ICD Patients Undergoing Battery Change And Complication Rate
    • 3.6.1 Percentage Of ICD Patients Undergoing Battery Change
    • 3.6.2 Complication Rate
  • 3.7 Assessment Of Trials On ICD Therapies
    • 3.7.1 Multisite Stimulation In Cardiomyopathy (Mustic) Trial
    • 3.7.2 Multicenter Insync Randomized Clinical Evaluations (Miracle) Trial
    • 3.7.3 Comparison Of Medical Therapy, Pacing, And Defibrillation In Hf (Companion) Trial
    • 3.7.4 Cardiac Resynchronization-hf (Care-hf) Trial
    • 3.7.5 Multicenter Automative Defibrillator Implantation With Cardiac Resynchronization Therapy (Madit-crt) Trial
    • 3.7.6 The Danish Study To Accessess The Efficiency Of Implantable Cardioverter Defibrillators In Patients Suffering From Nonischemic Systolic Heart Failure Mortality (Danish) Trial
    • 3.7.7 British Trial
  • 3.8 Industry Analysis Tools
    • 3.8.1 Porter's Analysis
    • 3.8.2 Macroeconomic Analysis

Chapter 4. Implantable Cardioverter Defibrillators Market: Product Type Analysis

  • 4.1 Product Type Movement Analysis & Market Share, 2023 & 2030
  • 4.2 Implantable Cardioverter Defibrillators Market Estimates & Forecast, By Product Type (USD Million)
  • 4.3 Transvenous Implantable Cardioverter Defibrillators (T-ICDs)
    • 4.3.1 Transvenous Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • 4.4 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
    • 4.4.1 Subcutaneous Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)

Chapter 5. Implantable Cardioverter Defibrillators Market: Type Analysis

  • 5.1 Type Movement Analysis & Market Share, 2023 & 2030
  • 5.2 Implantable Cardioverter Defibrillators Market Estimates & Forecast, By Type (USD Million)
  • 5.3 Single Chamber ICDs
    • 5.3.1 Common Conditions In Patients Using Single-chamber ICDs
    • 5.3.2 Single Chamber ICDs Market, 2018 - 2030 (USD Million)
  • 5.4 Dual Chamber ICDs
    • 5.4.1 Common Conditions In Patients Using Dual-chamber ICDs
    • 5.4.2 Dual Chamber ICDs Market, 2018 - 2030 (USD Million)
  • 5.5 Biventricular Devices
    • 5.5.1 Biventricular Devices Market, 2018 - 2030 (USD Million)

Chapter 6. Implantable Cardioverter Defibrillators Market: Nyha Class Analysis

  • 6.1 Nyha Class Movement Analysis & Market Share, 2023 & 2030
  • 6.2 Implantable Cardioverter Defibrillators Market Estimates & Forecast, By Nyha Class (USD Million)
  • 6.3 Nyha Class Ii
    • 6.3.1 Nyha Class Ii Market, 2018 - 2030 (USD Million)
  • 6.4 Nyha Class Iii
    • 6.4.1 Nyha Class Iii Market, 2018 - 2030 (USD Million)

Chapter 7. Implantable Cardioverter Defibrillators Market: End-use Analysis

  • 7.1 End-use Movement Analysis & Market Share, 2023 & 2030
  • 7.2 Implantable Cardioverter Defibrillators Market Estimates & Forecast, By End-use (USD Million)
  • 7.3 Hospitals
    • 7.3.1 Variation Of ICD Implants As Per The Type Of Hospital
    • 7.3.2 Hospitals Market, 2018 - 2030 (USD Million)
  • 7.4 Ambulatory Surgical Centers
    • 7.4.1 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • 7.5 Others
    • 7.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 8. Implantable Cardioverter Defibrillators Market: Regional Estimates & Trend Analysis

  • 8.1 Implantable Cardioverter Defibrillators Market: Regional Outlook
  • 8.2 North America
    • 8.2.1 North America Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 Key Country Dynamics
      • 8.2.2.2 U.S. Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Key Country Dynamics
      • 8.2.3.2 Technology Used By Vendors For Patient Monitoring In Canada
      • 8.2.3.3 Canada Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2 UK
      • 8.3.2.1 Key Country Dynamics
      • 8.3.2.2 Hypertension Cases In UK
      • 8.3.2.3 UK Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3 Germany
      • 8.3.3.1 Key Country Dynamics
      • 8.3.3.2 Germany Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4 France
      • 8.3.4.1 Key Country Dynamics
      • 8.3.4.2 France Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5 Italy
      • 8.3.5.1 Key Country Dynamics
      • 8.3.5.2 Causes Of Replacement According To Indication
      • 8.3.5.3 Italy Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6 Spain
      • 8.3.6.1 Key Country Dynamics
      • 8.3.6.2 Spain Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7 Denmark
      • 8.3.7.1 Key Country Dynamics
      • 8.3.7.2 Denmark Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8 Sweden
      • 8.3.8.1 Key Country Dynamics
      • 8.3.8.2 Sweden Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9 Norway
      • 8.3.9.1 Key Country Dynamics
      • 8.3.9.2 Norway Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Key Country Dynamics
      • 8.4.2.2 Japan Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 Key Country Dynamics
      • 8.4.3.2 China Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 Key Country Dynamics
      • 8.4.4.2 India Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5 Australia
      • 8.4.5.1 Key Country Dynamics
      • 8.4.5.2 Australia Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6 South Korea
      • 8.4.6.1 Key Country Dynamics
      • 8.4.6.2 South Korea Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7 Thailand
      • 8.4.7.1 Key Country Dynamics
      • 8.4.7.2 Thailand Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Key Country Dynamics
      • 8.5.2.2 Brazil Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Key Country Dynamics
      • 8.5.3.2 Mexico Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Key Country Dynamics
      • 8.5.4.2 Argentina Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6 Middle East & Africa (Mea)
    • 8.6.1 Mea Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 Key Country Dynamics
      • 8.6.2.2 South Africa Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Key Country Dynamics
      • 8.6.3.2 Saudi Arabia Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4 UAE
      • 8.6.4.1 Key Country Dynamics
      • 8.6.4.2 UAE Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5 Kuwait
      • 8.6.5.1 Key Country Dynamics
      • 8.6.5.2 Kuwait Implantable Cardioverter Defibrillators Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Analysis

  • 9.1 Company Categorization
  • 9.2 Participants' Overview
  • 9.3 Financial Performance
  • 9.4 Product Benchmarking
  • 9.5 Company Market Position Analysis
    • 9.5.1 Heat Map Analysis
  • 9.6 Swot-analysis
    • 9.6.1 Abbott
    • 9.6.2 Medtronic
    • 9.6.3 Biotronik Se & Co. Kg
    • 9.6.4 Boston Scientific Corporation
    • 9.6.5 Microport Scientific Corporation
    • 9.6.6 Livanova Plc
  • 9.7 Company Market Share Analysis, 2023
  • 9.8 Strategy Mapping
    • 9.8.1 Mergers & Acquisitions
    • 9.8.2 Product Launch
    • 9.8.3 Partnerships & Collaborations
    • 9.8.4 Product Approvals
    • 9.8.5 Others

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Volume of ICD patients suffering heart failure
  • Table 4 Percentage Of ICD Patients Undergoing Battery Change
  • Table 5 Global Implantable Cardioverter Defibrillators Market Revenue Estimates And Forecast, By Product Type, 2018 - 2030 (USD Million)
  • Table 6 Global Implantable Cardioverter Defibrillators Market Revenue Estimates And Forecast, By Type, 2018 - 2030 (USD Million)
  • Table 7 Global Implantable Cardioverter Defibrillators Market Revenue Estimates And Forecast, By NYHA Class, 2018 - 2030 (USD Million)
  • Table 8 Global Implantable Cardioverter Defibrillators Market Revenue Estimates And Forecast, By End-use, 2018 - 2030 (USD Million)
  • Table 9 Participant Organizations Involved in The Escape-Net Study-
  • Table 10 Key Companies Undertaking Mergers & Acquisitions.
  • Table 11 Key Companies Undertaking Product Launch
  • Table 12 Key Companies Undergoing Partnerships & Collaborations
  • Table 13 Key Companies Undergoing Product Approvals
  • Table 14 Key Companies Undergoing Others

List of Figures

  • Fig. 1 Implantable Cardioverter Defibrillators Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Information Procurement
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modelling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Market Snapshot
  • Fig. 10 Segment Snapshot - 1
  • Fig. 11 Segment Snapshot - 2
  • Fig. 12 Competitive Landscape
  • Fig. 13 Cardiac Rhythm Management Devices Market Value, 2023 (USD Billion)
  • Fig. 14 Implantable Cardioverter Defibrillators Market Dynamics
  • Fig. 15 Implantable Cardioverter Defibrillators Market: PORTER's Analysis
  • Fig. 16 Implantable Cardioverter Defibrillators Market: PESTEL Analysis
  • Fig. 17 Implantable Cardioverter Defibrillators Market: By Product Type: Key Takeaways
  • Fig. 18 Implantable Cardioverter Defibrillators Market, By Product Type: Market Share, 2023 & 2030
  • Fig. 19 Transvenous Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 20 Subcutaneous Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 21 Implantable Cardioverter Defibrillators Market: By Type: Key Takeaways
  • Fig. 22 Implantable Cardioverter Defibrillators Market, By Type: Market Share, 2023 & 2030
  • Fig. 23 Common Conditions in Patients Using Single-Chamber ICDs
  • Fig. 24 Single Chamber ICDs Market, 2018 - 2030 (USD Million)
  • Fig. 25 Common Conditions in Patients Using Dual-Chamber ICDs
  • Fig. 26 Dual Chamber ICDs Market, 2018 - 2030 (USD Million)
  • Fig. 27 Biventricular Devices Market, 2018 - 2030 (USD Million)
  • Fig. 28 Implantable Cardioverter Defibrillators Market: By NYHA Class: Key Takeaways
  • Fig. 29 Implantable Cardioverter Defibrillators Market, By NYHA Class: Market Share, 2023 & 2030
  • Fig. 30 NYHA Class II market, 2018 - 2030 (USD Million)
  • Fig. 31 NYHA Class III Market, 2018 - 2030 (USD Million)
  • Fig. 32 Implantable Cardioverter Defibrillators Market, By End-Use: Key Takeaways
  • Fig. 33 Implantable Cardioverter Defibrillators Market, By End-Use: Market Share, 2023 & 2030
  • Fig. 34 Variation of ICD implants as per the type of hospitals
  • Fig. 35 Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 36 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • Fig. 37 Others Market, 2018 - 2030 (USD Million)
  • Fig. 38 Implantable Cardioverter Defibrillators Market Revenue, By Region, 2023 & 2030 (USD Million)
  • Fig. 39 Regional Marketplace: Key Takeaways
  • Fig. 40 Regional Marketplace: Key Takeaways
  • Fig. 41 North America Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 43 Key Country Dynamics
  • Fig. 44 Technology Used by Vendors for Patient Monitoring in Canada
  • Fig. 45 Canada Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 46 Europe Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 47 Key Country Dynamics
  • Fig. 48 Hypertension Cases In UK (in Million)
  • Fig. 49 UK Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 50 Key Country Dynamics
  • Fig. 51 Germany Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 52 Key Country Dynamics
  • Fig. 53 France Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 54 Key Country Dynamics
  • Fig. 55 Causes of Replacement According to Indication
  • Fig. 56 Italy Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 57 Key Country Dynamics
  • Fig. 58 Spain Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 59 Key Country Dynamics
  • Fig. 60 Denmark Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 61 Key Country Dynamics
  • Fig. 62 Sweden Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 63 Key Country Dynamics
  • Fig. 64 Norway Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 Japan Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 China Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 India Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 Australia Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 South Korea Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 76 Key Country Dynamics
  • Fig. 77 Thailand Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 78 Latin America Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 79 Key Country Dynamics
  • Fig. 80 Brazil Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 81 Key Country Dynamics
  • Fig. 82 Mexico Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 83 Key Country Dynamics
  • Fig. 84 Argentina Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 85 MEA Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 86 Key Country Dynamics
  • Fig. 87 South Africa Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 88 Key Country Dynamics
  • Fig. 89 Saudi Arabia Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 90 Key Country Dynamics
  • Fig. 91 UAE Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 92 Key Country Dynamics
  • Fig. 93 Kuwait Implantable Cardioverter Defibrillators Market, 2018 - 2030 (USD Million)
  • Fig. 94 Key Company Categorization
  • Fig. 95 Abbott-SWOT analysis
  • Fig. 96 Medtronic-SWOT analysis
  • Fig. 97 BIOTRONIK SE & Co. KG -SWOT analysis
  • Fig. 98 Boston Scientific Corporation-SWOT analysis
  • Fig. 99 MicroPort Scientific Corporation-SWOT analysis
  • Fig. 100 LivaNova PLC-SWOT analysis
  • Fig. 101 Company Market Share Analysis, 2023
  • Fig. 102 Strategy Mapping